Funding · Company
Brenig Therapeutics, Inc.
Dover, DEBiotech & Pharma
Brenig Therapeutics, Inc. of Dover, DE has disclosed $30M across 1 Form D offering filed with the SEC on Jul 30, 2024.
$30M
Total disclosed
1
Form D offering
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$30M
Form D · Jul 30, 2024 ↗
Q3 2024
· target $65M
Filing details
HeadquartersDover, DEIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0002030788Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →